This conclusion is consistent with the results of several studies of BRCA1 carriers, which found that most serous cancers present at an advanced stage [32],[38],[39], and with screening studies, which also find that most of these cancers are already advanced when discovered, whether by conventional screening or by symptomatic presentation [23],[40]–[49]. This evidence concerns the gene BRCA1 and cancer.